{"name":"IDEA AG","slug":"idea-ag","ticker":"","exchange":"","domain":"","description":"IDEA AG is a biopharmaceutical company focused on developing innovative treatments for various medical conditions. The company has a pipeline of six drugs, with several in advanced stages of clinical trials, including Diractin and IDEA-033.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Diractin","genericName":"Diractin","slug":"diractin","indication":"Other","status":"phase_2"},{"name":"IDE-161","genericName":"IDE-161","slug":"ide-161","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"IDE196","genericName":"IDE196","slug":"ide196","indication":"Non-small cell lung cancer","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"IDEA-033","genericName":"IDEA-033","slug":"idea-033","indication":"Atrial fibrillation for stroke prevention","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Ketoprofen in Transfersome","genericName":"Ketoprofen in Transfersome","slug":"ketoprofen-in-transfersome","indication":"Pain relief","status":"phase_2"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"ketoprofen in Diractin®","genericName":"ketoprofen in Diractin®","slug":"ketoprofen-in-diractin","indication":"Rheumatoid arthritis","status":"phase_3"}]}],"pipeline":[{"name":"Diractin","genericName":"Diractin","slug":"diractin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"IDE-161","genericName":"IDE-161","slug":"ide-161","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"IDE196","genericName":"IDE196","slug":"ide196","phase":"phase_2","mechanism":"Selective inhibitor of MEK1/2","indications":["Non-small cell lung cancer","Colorectal cancer"],"catalyst":""},{"name":"IDEA-033","genericName":"IDEA-033","slug":"idea-033","phase":"phase_3","mechanism":"IDEA-033 is a small molecule drug that targets the molecular target.","indications":["Atrial fibrillation for stroke prevention"],"catalyst":""},{"name":"Ketoprofen in Transfersome","genericName":"Ketoprofen in Transfersome","slug":"ketoprofen-in-transfersome","phase":"phase_2","mechanism":"Inhibits COX-2","indications":["Pain relief","Inflammation"],"catalyst":""},{"name":"ketoprofen in Diractin®","genericName":"ketoprofen in Diractin®","slug":"ketoprofen-in-diractin","phase":"phase_3","mechanism":"Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain.","indications":["Rheumatoid arthritis","Osteoarthritis","Ankylosing spondylitis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQM2Z4djktaHROTVVGb3lObzhTRnRheTZrLUtkNExzQkFXanYxQkkyWndBWU95NFA2V19ybEJsODEteU9WLTg1TW8waU5rcEoxWmE4MGNBU0lUSHBrWHRaclB5aFVyNTdYNEtSTjRoUE9KQW9ERW90QmxnZTBaQUVtMU82N21uRDRkRkEwRUdn?oc=5","date":"2026-03-24","type":"pipeline","source":"AgFunderNews","summary":"🎥 Future Food-Tech: Big ideas, hard truths, and the path to scale - AgFunderNews","headline":"🎥 Future Food-Tech: Big ideas, hard truths, and the path to scale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNVG9zRnFxeVdtUmdtLVNEakluODU4RWdrZnRYS2hIN0hsckQzamVkRFhsSFRkblBuS0diQWpoaVRqdHhmUERQc21kalJyM3d3RklHU2NpSG9hZW5HbTU0Ti0zdjdINjBTb1liQWRoaFI5aGxLLXlhck4yd0QzdmZmU0s4Wkl4dw?oc=5","date":"2026-02-03","type":"pipeline","source":"The Business Journals","summary":"Massachusetts joins 42 states in suing pharma giant over price fixing scheme - The Business Journals","headline":"Massachusetts joins 42 states in suing pharma giant over price fixing scheme","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPOUt1c2FrNmhjVHhCWXFqYTY0NGhKMDdNZ0d1UHBpVnVtcjcxMnctTjdyQU4wazh6UzczMkpraHlEQzd1aWM5WWt0Z3RkRHU1VV9uMWstbDQ4NllZVmdYUEJ6UGc2d2hNbGlkTFJJWDJ5R3djSWIybGlCdU5ULTZSVEk0Nms0dEFJN2RuYXZnSkVaMVg0Uk5PQlFiblV5cjF4YUVKUkdYYnA1endUOUNtczVBbUFZWjRXdUU4bQ?oc=5","date":"2026-01-04","type":"pipeline","source":"AD HOC NEWS","summary":"Novartis AG (ADR): Quiet Confidence Or Complacency? A Deep Look At NVS After A Steady Climb - AD HOC NEWS","headline":"Novartis AG (ADR): Quiet Confidence Or Complacency? A Deep Look At NVS After A Steady Climb","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNTlY4Q2JuLXBtMG1RTllDS1hWZEpQeHZTZlhuUkpLZTlZY0NKdFpnTGZZSXEzdEJGMl9mZnZDZmY3ZW9xeFVaY2YwdGRSS1V4RFpRR2VkSU1SWHpQWFJQbHBkQ0pmMFY1MHh5OFE1SldvRFBoNmJxZTlTaklpY01QSnVPQkstdG03VUlFdHJUSUg0bWF2NWVJQXM4YVROcnNwb1c4b24xc1BpSTg0VTF2YUNyOVpkUVRO?oc=5","date":"2025-12-16","type":"pipeline","source":"Stock Titan","summary":"Corteva (NYSE: CTVA), Hexagon Bio form first ag-pharma JV for crop protection - Stock Titan","headline":"Corteva (NYSE: CTVA), Hexagon Bio form first ag-pharma JV for crop protection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQaktHR04xVlBpQ3RxdWN3UXNmSUx1aUZCSmFSR1h0czlseTlUMlpHYUZpUVFFblVncjlORFpRcTltQTdXZHpHY1laSUFzRXVMalZNdUJvOC1KTnYxNTMwV0gzRjFuMnM2bTA3WjZLYmVwX0F4aGFHMEVKaGp2Mk1ZM0xPQVBvNVZzUk9EaUNWOEthSmdmZ3FzSUJ1dnpBWjRPRjl6OWN5NVBiRGc?oc=5","date":"2025-11-27","type":"pipeline","source":"Bloomberg.com","summary":"Xi-Trump Talks Revive Idea of a G-2 Running the World - Bloomberg.com","headline":"Xi-Trump Talks Revive Idea of a G-2 Running the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOQ1JrYnhoLWxyQk9lV0lvZ2wtamFzZzdpOTVTNkpVNmFWclhyeGRzLVRHYV9qbGh6aFRBWUJobHhwb18tdVIzSC1PWGJtQU92UlE1WlE3YW1nRTNYSUdtSkhfQ2FvaFJrRUlPbnA4OEp2SHpFTnQ3WEhHa2ZtR25zc1dXWjF5QTRLbnc2ZUlOempmNVZTcnZQdjBtNWlrU3FLTkZnT0ZjRUZKT3JIaVVmSGdXWFZ4ZWw2MXoyQw?oc=5","date":"2025-11-03","type":"pipeline","source":"Cyril Amarchand Mangaldas","summary":"Delhi High Court’s Ruling in F. Hoffmann-La Roche Ag & Anr. V. Natco Pharma - Cyril Amarchand Mangaldas","headline":"Delhi High Court’s Ruling in F. Hoffmann-La Roche Ag & Anr. V. Natco Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQcktWbWVOUWlRVWxUaVd4WXlWRFNrZVpWcHVwV3BnZGZ4RHc5ZmxyZGs1cW1IMXRRcHoxMkhYVUlja1VrdjVrYnkxTm9MemRDTzA0YzdyaW9kZG5XbEFPQWlyd3NON0ZFdWF3ZkkzempHR1hhMmxaZ2x4a2FKVFY3VUpyQlplMlFrcEFDZ3lvX2w3S0hmWEtXc1Q0YW5Zd1V0bV8teExPMkZKV2FDRHRKSTdpN2lhTmd3d1ZDQldCWV96amwyX25j?oc=5","date":"2025-05-19","type":"pipeline","source":"interpharma.ch","summary":"3 questions to our new Board members: David Traub, Managing Director of Novartis Pharma Schweiz AG - interpharma.ch","headline":"3 questions to our new Board members: David Traub, Managing Director of Novartis Pharma Schweiz AG","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQZ0hoVnh4UUpodHc1cEZ2dGY0eDltc1VEUmV4VkRTTUpBX2lRUkxOdm11Sm1tMXdDaVlUaVlFY2Q5VHBmaFUxNDBMWEh2V21tVHlhZHJkQ1psTmxvLXpJOWtkVXEzb054aUE3cjhCd0ZYZlpPRW14WmxLYklMUERQMFNHejlQOEVyVU53c1kxd0Q3OXlac01QUXlueXhXOEZfc0VxNUFGZXNRb3hka2NPandQN01JSTgx?oc=5","date":"2025-05-15","type":"trial","source":"AgFunderNews","summary":"IdeeLab achieves CDMO status with new industrial-scale facility for ag biological production - AgFunderNews","headline":"IdeeLab achieves CDMO status with new industrial-scale facility for ag biological production","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNcm43bHRHeXhPQjVkcmNaV3pEcXZXbEFSQ3JZc3VxTmNnRC1MbDNSWWtlZHJkOXBkYlFIbHpyRFpWNzgwWGYydGRwQ0ZrY2EyWWY2bjlCaTZpbk1sQzlITm1KbHdoVWZUY0JtbndzNmNuZ0NNdG4yRnJZTE1CM1BTSDlMaWo0N041?oc=5","date":"2025-03-17","type":"pipeline","source":"Purdue University - College of Agriculture","summary":"More ideas for new pharmaceuticals, faster - Purdue University - College of Agriculture","headline":"More ideas for new pharmaceuticals, faster - Purdue University","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNem05aVpsVmFUcC1yZ2JuTVgwQkZRSTZiak9xMjlKd3UwU2hhVElEcWRqQUZKbkRUa3cxODZIZkVhQm9nWnk2X3NmRTVQc21aSm1oNXUwZmhIMGlOR1Fobm1uRVdoN21jb2l6Mm1yR1VJc0ZBSXZyd2J3cTcwTUFoTnhUZk9EeXNlVkpr?oc=5","date":"2024-11-27","type":"pipeline","source":"The New York Times","summary":"On Big Pharma, Food and Agriculture, These Are Kennedy’s Unexpected Bedfellows (Published 2024) - The New York Times","headline":"On Big Pharma, Food and Agriculture, These Are Kennedy’s Unexpected Bedfellows (Published 2024)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQSWpXaWJMU0dvUU1yYndraHZQdjA0M2FHQnY2ZzdrLWFjSVZUS0ptcmlvUUxRY2RCMlNXVzM2QmtVWldBNVA4dlM1eTZBZTQzcV9wMV9fTlM1Y19WRHQxVGlkXzVKZDlXZ3l3cnZGekNlR1VoNzMwWERuS0ZTNFUtaWRFaXJMQm0tUUdlNTdDZDYzNlZjR0NqRHNNRUVsQWt5TnNnMUFETnBIenNkbkZOemtTWW85cXc5RTJudEFNU3pRMGNQMFRiV1Fn?oc=5","date":"2024-10-28","type":"pipeline","source":"DeSmog","summary":"Mapped: How Big Ag, Pharma, Pesticides and Other Industries Hope to Sway the UN Biodiversity Talks - DeSmog","headline":"Mapped: How Big Ag, Pharma, Pesticides and Other Industries Hope to Sway the UN Biodiversity Talks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPcnVhWEhQbEFyTTRhMnowTmZqT1BabU1Cd3h6VlR3QzRsUUVSQXlBQm1kWFdQdDRhQWstN0JuSE1JbFZyNkhpekxpR0RsZTdMb0EwWHlCaTY4b19OSHdlU1hwUTdPb2c1cllYQlN0MWFoSThFUXRmU1N1Q2diNTI4Y1g4bDlQTVVkWjd5MlFKX0NJOGh0d0FVc2M3eF9qYlBBd3FZeUpuVWl1V2FsSUE?oc=5","date":"2024-09-30","type":"pipeline","source":"South Dakota Searchlight","summary":"Clarity needed over glyphosate misbranding at state, fed levels - South Dakota Searchlight","headline":"Clarity needed over glyphosate misbranding at state, fed levels","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_2":3,"phase_1":1,"phase_3":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}